20 unchanged sentences
This report appears below.
−Removed: Report of I ndependent Registered Public Accounting Firm
+Added: Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of Kymera Therapeutics, Inc.
52 unchanged sentences
Description of Securities (Incorporated by reference to Exhibit 4.3 to the Registrant’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 11, 2021).
+Added: Form of Pre-Funded Warrant (Incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 19, 2022).
2018 Stock Option and Grant Plan, and form of award agreements thereunder (Incorporated by reference to Exhibit 10.1 to the Registrant’s Registration Statement on Form S-1 (File No.
8 unchanged sentences
333-240264) filed with the Securities and Exchange Commission on August 17, 2020).
−Removed: Lease Agreement between the Registrant and ARE-TECH SQUARE, LLC, dated as of February 28, 2018 (Incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-240264) filed with the Securities and Exchange Commission on July 31, 2020).
Lease between the Registrant and Arsenal Yards Holding LLC, dated as of August 15, 2019 (Incorporated by reference to Exhibit 10.8 to the Registrant’s Registration Statement on Form S-1 (File No.
4 unchanged sentences
333-240264) filed with the Securities and Exchange Commission on July 31, 2020).
−Removed: Collaboration Agreement between the Registrant and GlaxoSmithKline Intellectual Property Development Limited, dated as of October 3, 2017 (Incorporated by reference to Exhibit 10.12 to the Registrant’s Registration Statement on Form S-1/A (File No.
−Removed: 333-240264) filed with the Securities and Exchange Commission on August 5, 2020).
−Removed: Collaboration and License Agreement between the Registrant and Genzyme Corporation, dated as of July 7, 2020 (Incorporated by reference to Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-240264) filed with the Securities and Exchange Commission on July 31, 2020).
−Removed: First Amendment to Collaboration Agreement between the Registrant and GlaxoSmithKline Intellectual Property Development Limited, dated as of August 27, 2020 (Incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2020).
+Added: Amended and Restated Collaboration and License Agreement between the Registrant and Genzyme Corporation, dated as of November 15, 2022.
First Amendment to Master Collaboration Agreement between the Registrant and Vertex Pharmaceuticals Incorporated, dated as of August 27, 2020 (Incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2020).
2 unchanged sentences
75, LLC dated as of December 20, 2021.
+Added: Securities Purchase Agreement, dated August 18, 2022, by and among the Registrant and the persons party thereto (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on form 8-K filed with the Securities and Exchange Commission on August 19, 2022).
+Added: Registration Rights Agreement, dated August 18, 2022, by and among the Registrant and the persons party thereto (Incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 19, 2022).
List of Subsidiaries of Registrant.
52 unchanged sentences
Pamela Esposito, PhD
−Removed: /s/ Steve Hall, PhD
−Removed: February 24, 2022
−Removed: Steve Hall, PhD
/s/ Joanna Horobin, MB, ChB
7 unchanged sentences
Maraganore, PhD
−Removed: /s/ Donald W.
−Removed: Nicholson, PhD
+Added: /s/ Leigh Morgan
February 23, 2023
−Removed: Nicholson, PhD
/s/ Elena, Ridloff, CFA
1 unchanged sentence
Elena Ridloff, CFA
+Added: /s/ Victor Sandor
+Added: February 23, 2023
+Added: Victor Sandor
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.